Cell-based Cancer Immunotherapy
Garg, Abhishek, Galluzzi, Lorenzo
- 出版商: Academic Press
- 出版日期: 2024-03-05
- 售價: $6,120
- 貴賓價: 9.5 折 $5,814
- 語言: 英文
- 頁數: 318
- 裝訂: Hardcover - also called cloth, retail trade, or trade
- ISBN: 0443139954
- ISBN-13: 9780443139956
海外代購書籍(需單獨結帳)
相關主題
商品描述
Cell-based Cancer Immunotherapy, Volume 183 provides the latest progress concerning research on anticancer cellular immunotherapies and their immunological, translation, or clinical aspects. Topics covered in this volume include Methods behind clinical DC vaccine products against glioblastoma, Fully closed and automated isolation of natural blood dendritic cells for cancer immunotherapy, Methods behind Oncolytic virus-based DC vaccines in cancer: towards a multiphase combined treatment strategy for Glioblastoma (GBM) patients, Identification of TCR repertoire patterns linked with anti-cancer immunotherapy, Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells, Methods behind neoantigen predictions for anticancer vaccines, Methods behind CD137L-DC-EBV-VAX anticancer vaccine, and much more. Additional sections cover Gold Standard Assessment of Immunogenic Cell Death Induced by Photodynamic Therapy: From In Vitro to Tumor Mouse Models and Anti-Cancer Vaccination Strategies, Methods behind TCR analyses for colorectal cancer-associated TILs, The use of xCELLigence, Incucyte, and/or Cr/LDH/maker-release assays, Humanized mouse models for anti-cancer therapy, In vitro re-challenge of CAR T cells, Methods behind adoptively transferred tumor draining lymphocytes? for anticancer immunotherapy, and A murine glioblastoma platform to test cellular therapies with the standard of care.
商品描述(中文翻譯)
《細胞免疫治療癌症,第183卷》提供了關於抗癌細胞免疫療法及其免疫學、轉化或臨床方面的最新研究進展。本卷涵蓋的主題包括針對膠芽腫的臨床DC疫苗產品背後的方法,用於癌症免疫療法的全封閉和自動化分離天然血液樹突細胞的方法,基於溶瘤病毒的DC疫苗在癌症治療中的方法:朝著一種多階段結合治療策略的膠芽腫(GBM)患者,與抗癌免疫療法相關的TCR重排模式的鑑定,使用健康供體衍生的癌特異性T細胞訓練表位-TCR預測模型的方法,用於抗癌疫苗的新抗原預測方法,CD137L-DC-EBV-VAX抗癌疫苗的方法等等。其他部分涵蓋了光動力療法誘導的免疫原性細胞死亡的黃金標準評估:從體外到腫瘤小鼠模型和抗癌疫苗策略,用於結腸直腸癌相關TIL的TCR分析方法,使用xCELLigence、Incucyte和/或Cr/LDH/maker-release測試的方法,用於抗癌治療的人類化小鼠模型,CAR T細胞的體外再挑戰方法,用於抗癌免疫療法的轉移腫瘤引流淋巴細胞的方法,以及用於測試標準護理的小鼠膠芽腫平台的細胞療法等等。